Royalty Pharma hikes dividend by 6.8%

Royalty Pharma (RPRX) announced a dividend increase on January 9, 2026, raising its quarterly payout by 6.8% to $0.235 per share.

The increase marks the sixth consecutive year of dividend growth for Royalty Pharma and represents the company’s largest dividend hike since 2022. Based on a share price of $40.36, the dividend corresponds to a yield of approximately 2.3%. The ex-dividend date is February 20, 2026.

Royalty Pharma acquires and manages pharmaceutical royalties, generating cash flows from a diversified portfolio of approved and late-stage biopharmaceutical products. More information is available on the website of Royalty Pharma.

Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Investors should conduct their own research or consult with a financial advisor before making any investment decisions.